MeSH D005831 - female genital diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D052776:Female urogenital diseases
0 Companies
0 Drugs
Success rate
D000091662:Genital diseases
0 Companies
0 Drugs
Success rate
D005831:
Female genital diseases
D000291:Adnexal diseases
0 Companies
0 Drugs
Success rate
D004414:Dyspareunia
D004715:Endometriosis
D006175:Gynatresia
0 Companies
0 Drugs
Success rate
D006558:Herpes genitalis
D007247:Female infertility
D014384:Female genital tuberculosis
0 Companies
0 Drugs
Success rate
D014591:Uterine diseases
0 Companies
0 Drugs
Success rate
D014623:Vaginal diseases
0 Companies
0 Drugs
Success rate
D014845:Vulvar diseases
0 Companies
0 Drugs
Success rate
D052065:Vaginismus
0 Companies
0 Drugs
Success rate
D060737:Reproductive tract infections
0 Companies
0 Drugs
Success rate
D005833:Female genital neoplasms
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
57%12/21
Phase 3
13%2/16
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use